| Literature DB >> 35208232 |
Peiwen Zhang1,2, You Zhou3, Deqiang Qin1, Jianjun Chen2, Zhixiang Zhang1.
Abstract
Biological control is a key component of integrated pest management (IPM). To suppress pests in a certain threshold, chemical control is used in combination with biological and other control methods. An essential premise for using pesticides in IPM is to ascertain their compatibility with beneficial insects. Chrysopa sinica (Neuroptera: Chrysopidae) is an important predator of various pests and used for pest management. This study was intended to analyze metabolic changes in C. sinica larvae after feeding on azadirachtin-treated Plutella xylostella (Lepidoptera, Plutellidae) larvae through a non-targeted LC-MS (Liquid chromatography-mass spectrometry) based metabolomics analysis. Results showed that C. sinica larvae did not die after consuming P. xylostella larvae treated with azadirachtin. However, their pupation and eclosion were adversely affected, resulting in an impairment in the completion of their life cycle. Feeding C. sinica larvae with azadirachtin-treated P. xylostella larvae affected over 10,000 metabolites across more than 20 pathways, including the metabolism of amino acids, carbohydrates, lipid, cofactors, and vitamins in C. sinica larvae, of which changes in amnio acid metabolism were particularly pronounced. A working model was proposed to illustrate differential changes in 20 metabolites related to some amino acid metabolisms. Among them, 15 were markedly reduced and only five were elevated. Our results suggest that azadirachtin application may not be exclusively compatible with the use of the predator C. sinica for control of P. xylostella. It is recommended that the compatibility should be evaluated not only based on the survival of the predatory insects but also by the metabolic changes and the resultant detrimental effects on their development.Entities:
Keywords: Chrysopa sinica; Plutella xylostella; azadirachtin; biological control; metabolomics
Year: 2022 PMID: 35208232 PMCID: PMC8876581 DOI: 10.3390/metabo12020158
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1The process of monitoring P. xylostella larvae feeding on cabbage leaves and C. sinica larvae ingesting azadirachtin-treated P. xylostella larvae and subsequently their pupation and eclosion. A larva feeding on a cabbage leaf treated with azadirachtin (a). A C. sinica larva ingesting a P. xylostella larva (b). C. sinica larvae underwent pupation from curling to the formation of cocoon (c-1–c-4). The emergence of C. sinica adult: a deformed adult (d-1), normal adult (d-2), and normal adult after removing wings to show normal abdomen (d-3).
Figure 2The proportion of mature C. sinica larvae underwent pupation (a) and eclosion (b) after ingesting azadirachtin-treated P. xylostella larvae. Data were expressed as the mean ± S.E. and ** and *** indicate significant differences at p < 0.01 and p < 0.001 levels based on Tukey’s HSD test.
Figure 3PLS-DA (partial least squares discriminant analysis) score plots derived from (a) positive ion mode (ESI+) and (b) negative ion mode (ESI−) in LC–MS metabolite profiles of C. sinica larvae.
Figure 4OPLS-DA (partial least squares discriminant analysis) score plots (left) with corresponding permutation test plots (right) derived from (a) positive ion mode (ESI+) and (b) negative ion mode (ESI−) in LC–MS metabolite profiles of C. sinica larvae.
Figure 5Representative total ion current (TIC) chromatograms of C. sinica larvae tissue extracts obtained from (a) positive ion mode (ESI+) and (b) negative ion mode (ESI−) in LC–MS. Left plots were treatment samples (T), and right plots were control samples (CK).
Differentially abundant metabolites identified in ESI+ and ESI− modes of LC–MS analysis of extracts derived from C. sinica larvae fed azadirachtin-treated P. xylostella larvae in contrast to those from the control treatment.
| Mode | KEGG Class | Pathway | Regulation | VIP ‡ | Name | Formula | M/Z § | |
|---|---|---|---|---|---|---|---|---|
|
| Amino acid metabolism | Glycine, serine, and threonine metabolism | down | 6.86 × 10−3 | 11.98 | Choline | C5H13NO | 104.1068832 |
| Arginine and proline metabolism | up | 9.49 × 10−3 | 1.75 | Putrescine | C4H12N2 | 89.10725487 | ||
| Lysine degradation | down | 4.08 × 10−2 | 1.33 | Cadaverine | C5H14N2 | 103.122903 | ||
| Tryptophan metabolism | down | 3.44 × 10−2 | 1.11 | Indole | C8H7N | 118.0650873 | ||
| Lysine biosynthesis | down | 2.11 × 10−6 | 2.07 | L-Saccharopine | C11H20N2O6 | 277.1390289 | ||
| Phenylalanine metabolism | down | 2.18 × 10−2 | 5.22 | Phenylacetaldehyde | C8H8O | 121.0647704 | ||
| Arginine biosynthesis | down | 5.84 × 10−3 | 2.74 | L-Citrulline | C6H13N3O3 | 176.1028923 | ||
| Arginine and proline metabolism | up | 8.30 × 10−4 | 11.94 | Spermidine | C7H19N3 | 146.1651255 | ||
| Tryptophan metabolism | down | 1.83 × 10−2 | 5.89 | L-Kynurenine | C10H12N2O3 | 209.0919249 | ||
| Arginine and proline metabolism | down | 9.08 × 10−3 | 4.49 | Agmatine | C5H14N4 | 131.1290899 | ||
| Arginine and proline metabolism | up | 3.60 × 10−3 | 2.51 | 1-Pyrroline-4-hydroxy-2-carboxylate | C5H7NO3 | 130.0498415 | ||
| Histidine metabolism | down | 2.19 × 10−2 | 2.51 | Urocanic acid | C6H6N2O2 | 139.0502099 | ||
| Lysine degradation | up | 1.17 × 10−2 | 2.85 | Deoxycarnitine | C7H15NO2 | 146.1175269 | ||
| Lysine degradation | down | 1.27 × 10−3 | 2.68 | L-Pipecolic acid | C6H11NO2 | 130.0862821 | ||
| Arginine and proline metabolism | down | 2.11 × 10−2 | 1.28 | N-Succinyl-L-glutamate | C9H13NO7 | 248.2077594 | ||
| Cysteine and methionine metabolism | up | 2.01 × 10−3 | 3.80 | Sulfite | SO32- | 83.084995 | ||
| Carbohydrate metabolism | Glyoxylate and dicarboxylate metabolism | down | 2.99 × 10−3 | 4.62 | L-threo-3-Methylaspartate | C5H9NO4 | 148.0603521 | |
| Amino sugar and nucleotide sugar metabolism | down | 1.80 × 10−3 | 1.72 | N-Acetylneuraminate | C11H19NO9 | 310.1127173 | ||
| Amino sugar and nucleotide sugar metabolism | up | 1.47 × 10−2 | 1.72 | CDP-abequose | C15H25N3O14P2 | 534.3283127 | ||
| Pentose and glucuronate interconversions | down | 3.45 × 10−4 | 16.41 | CDP-ribitol | C14H25N3O15P2 | 538.3194126 | ||
| Amino sugar and nucleotide sugar metabolism | down | 2.76 × 10−3 | 1.13 | UDP-L-Ara4N | C14H23N3O15P2 | 536.3039803 | ||
| Amino sugar and nucleotide sugar metabolism | down | 7.69 × 10−4 | 1.18 | CDP-4-dehydro-3,6-dideoxy-D-glucose | C15H23N3O14P2 | 532.3185085 | ||
| Amino sugar and nucleotide sugar metabolism | down | 4.66 × 10−3 | 2.99 | N-Acetylmuramic acid 6-phosphate | C11H20NO11P | 374.2531432 | ||
| Digestive system | Bile secretion | down | 1.26 × 10−2 | 7.39 | L-Carnitine | C7H15NO3 | 162.1123783 | |
| Bile secretion | down | 3.80 × 10−4 | 6.22 | Acyclovir | C8H11N5O3 | 226.216309 | ||
| Lipid metabolism | Glycerophospholipid metabolism | up | 1.57 × 10−2 | 7.49 | sn-Glycero-3-phosphocholine | C8H21NO6P+ | 258.1097776 | |
| Glycerophospholipid metabolism | up | 4.97 × 10−2 | 2.77 | LysoPC(16:1(9Z)) | C24H48NO7P | 494.3234809 | ||
| Glycerophospholipid metabolism | up | 3.07 × 10−2 | 3.58 | Glycerylphosphorylethanolamine | C5H14NO6P | 216.062969 | ||
| Membrane transport | ABC transporters | up | 1.58 × 10−3 | 1.84 | Ferrichrome | C27H42FeN9O12 | 741.5250124 | |
| ABC transporters | down | 1.28 × 10−3 | 2.09 | Mannopine | C11H22N2O8 | 311.3132994 | ||
| Metabolism of cofactors and vitamins | Porphyrin and chlorophyll metabolism | up | 4.05 × 10−3 | 1.01 | Biliverdin | C33H34N4O6 | 583.2537613 | |
| Biotin metabolism | down | 4.20 × 10−3 | 1.06 | Biotin | C10H16N2O3S | 245.0953355 | ||
| Thiamine metabolism | up | 2.49 × 10−3 | 2.39 | Thiamin triphosphate | C12H19N4O10P3S | 506.2968678 | ||
| Nicotinate and nicotinamide metabolism | down | 1.75 × 10−2 | 1.09 | 2,3-Dimethylmaleate | C6H8O4 | 145.1335282 | ||
| Metabolism of other amino acids | beta-Alanine metabolism | up | 3.18 × 10−3 | 3.47 | Pantothenic acid | C9H17NO5 | 220.1178677 | |
|
| Amino acid metabolism | Valine, leucine and isoleucine degradation | down | 3.54 × 10−3 | 2.84 | L-VALINE | C5H11NO2 | 116.0717418 |
| Lysine biosynthesis | down | 3.88 × 10−3 | 3.80 | L-LYSINE | C6H14N2O2 | 145.098347 | ||
| Tryptophan metabolism | down | 1.95 × 10−2 | 1.18 | 5-Hydroxyindoleacetic acid | C10H9NO3 | 190.0509535 | ||
| Lysine biosynthesis | down | 7.28 × 10−6 | 1.02 | L-Saccharopine | C11H20N2O6 | 275.1248028 | ||
| Alanine, aspartate and glutamate metabolism | up | 2.46 × 10−2 | 1.09 | Succinic acid semialdehyde | C4H6O3 | 101.0244019 | ||
| Biosynthesis of other secondary metabolites | Caffeine metabolism | down | 5.30 × 10−3 | 1.07 | 7-Methylxanthosine | C11H15N4O6 | 298.2467506 | |
| Carbohydrate metabolism | Citrate cycle (TCA cycle) | down | 9.43 × 10−3 | 1.64 | Succinic acid | C4H6O4 | 117.0193765 | |
| Pentose and glucuronate interconversions | up | 1.46 × 10−3 | 1.60 | Ribitol | C5H12O5 | 151.0611315 | ||
| Glycolysis / Gluconeogenesis | up | 2.63 × 10−5 | 2.23 | D-Glycerate 3-phosphate | C3H7O7P | 184.9855899 | ||
| Fructose and mannose metabolism | up | 4.08 × 10−2 | 3.58 | Mannitol | C6H14O6 | 181.0717565 | ||
| Amino sugar and nucleotide sugar metabolism | down | 2.78 × 10−3 | 1.02 | Uridine diphosphate-N-acetylglucosamine | C17H27N3O17P2 | 606.0741142 | ||
| C5-Branched dibasic acid metabolism | up | 4.61 × 10−2 | 1.54 | Itaconate, Itaconic acid | C5H6O4 | 129.0194034 | ||
| Ascorbate and aldarate metabolism | up | 5.48 × 10−3 | 1.48 | Threonic acid | C4H8O5 | 135.0299386 | ||
| Galactose metabolism | up | 9.68 × 10−3 | 2.24 | Tagatose | C6H12O6 | 179.0560745 | ||
| Pentose and glucuronate interconversions | down | 1.10 × 10−3 | 2.43 | CDP-ribitol | C14H25N3O15P2 | 536.3041792 | ||
| Pentose and glucuronate interconversions | down | 3.65 × 10−4 | 11.32 | CDP-ribitol | C14H25N3O15P2 | 536.3053925 | ||
| Amino sugar and nucleotide sugar metabolism | up | 8.30 × 10−4 | 1.31 | CMP-pseudaminic acid | C22H34N5O15P | 638.5000382 | ||
| Energy metabolism | Oxidative phosphorylation | down | 9.09 × 10−3 | 1.12 | Pyrophosphate | P2O74− | 176.935889 | |
| Lipid metabolism | Fatty acid biosynthesis | up | 2.72 × 10−3 | 11.07 | Caprylic acid | C8H16O2 | 143.1077396 | |
| Fatty acid biosynthesis | up | 7.01 × 10−6 | 15.37 | Myristic acid | C14H28O2 | 227.2016801 | ||
| Fatty acid biosynthesis | down | 3.75 × 10−3 | 10.03 | Palmitoleic acid | C16H30O2 | 253.2172625 | ||
| Primary bile acid biosynthesis | up | 2.73 × 10−3 | 5.33 | Taurine | C2H7NO3S | 124.0073745 | ||
| Fatty acid biosynthesis | up | 7.76 × 10−3 | 5.94 | Palmitic acid | C16H32O2 | 255.2329072 | ||
| alpha-Linolenic acid metabolism | down | 1.33 × 10−3 | 5.58 | Linolenic Acid | C18H30O2 | 277.2171486 | ||
| Linoleic acid metabolism | down | 8.66 × 10−3 | 2.89 | 9-OxoODE | C18H30O3 | 293.2123043 | ||
| Biosynthesis of unsaturated fatty acids | down | 6.24 × 10−3 | 1.21 | Arachidic acid | C20H40O2 | 311.2954346 | ||
| Membrane transport | ABC transporters | up | 6.64 × 10−3 | 4.01 | Ferrichrome | C27H42FeN9O12 | 739.5113096 | |
| Metabolism of cofactors and vitamins | Folate biosynthesis | down | 3.34 × 10−3 | 4.26 | 2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-dihydropteridine | C9H13N5O4 | 254.2205895 | |
| Ubiquinone and other terpenoid-quinone biosynthesis | down | 7.16 × 10−4 | 1.66 | (1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate | C11H12O6 | 239.2015915 | ||
| Folate biosynthesis | down | 3.34 × 10−2 | 1.37 | Neopterin | C9H11N5O4 | 252.2049325 | ||
| Metabolism of other amino acids | beta-Alanine metabolism | up | 1.37 × 10−2 | 1.77 | Pantothenic Acid (B5) | C9H17NO5 | 218.1033645 | |
| Sensory system | Inflammatory mediator regulation of TRP channels | down | 2.82 × 10−3 | 1.58 | Icilin | C16H13N3O4 | 310.2830475 |
KEGG is the major public pathway-related database that includes not only genes but metabolites. † Pathway enrichment analysis identified significantly enriched metabolic pathways or signal transduction pathways in differential metabolites comparing with the whole background. The calculating formula is as follows: . Here N is the number of all metabolites that with KEGG annotation, n is the number of differential metabolites in N, M is the number of all metabolites annotated to specific pathways, and m is number of differential metabolites in M. ‡ A variable importance in projection score of OPLS model was applied to rank the metabolites that best distinguished between two groups. § Means mass-to-charge ratio.
Figure 6Metabolome map of significant metabolic pathways in C. sinica larvae affected by the ingestion of azadirachtin-treated P. xylostella larvae (pathway enrichment). Rich factor refers to the ratio of the number of annotated to this pathway in the differential metabolites to the number of annotated to this pathway in all metabolites. A larger rich factor indicates a higher degree of enrichment. p values range from 0 to 1, the closer to 0, the more significance of the enrichment.
Figure 7Metabolic pathways related to amino acid metabolism in C. sinica larvae affected by the ingestion of azadirachtin-treated P. xylostella larvae. The blue arrows indicate decreased metabolites.